[Retracted] Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy

Table 1

Univariate analysis.

Factors	Single factors of PFS			Single factor of OS
	value	HR value	95% CI	value	HR value	95% CI
Age (≥60 years vs. <60 years)	0.437	1.231	0.729–2.080	0.736	1.096	0.644–1.864
Sex (male vs. female)	0.576	0.855	0.494–1.481	0.871	0.956	0.552–1.656
Clinical staging (III vs. IV)	0.497	0.834	0.495–1.407	0.006	2.272	1.272–4.055
Number of lymph node metastases (≥12 vs. <12)	0.674	0.895	0.533–1.501	0.012	0.490	0.280–0.858
Location of lesion (left colon vs. right colon)	0.185	1.424	0.845–2.401	0.657	1.128	0.663–1.920
lncRNA CASC9 (≥2.38 vs. <2.38)	0.014	2.079	1.160–3.727	0.941	1.022	0.571–1.829